JORDAN SHULL: Open Payments
NPI 1275152985 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: FANAPT, ARISTADA, Auvelity, INGREZZA, ERZOFRI EXTENDED-RELEASE, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
